Close
Loading...
CONTACT US
:
:
:
Call us at:
:
:
:
Fax:
Email:

LAIR1

Products

Loading...

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.

Background

Leukocyte-associated immunoglobulin-like receptor 1 (LAIR1), numbered CD305, with a molecular weight ranging from 32 to 40 kDa, is a type I transmembrane glycoprotein and a core member of the immunoglobulin superfamily. Its structure is not concentrated in a single location within the cell, but spans both the internal and external spaces of the cell, with each structural segment assigned a clear, distinct function that does not interfere with others. LAIR1 is widely expressed on various cells of hematopoietic origin, all of which are core participants in the body's immune work, including natural killer cells, T lymphocytes, B lymphocytes, monocytes, dendritic cells, eosinophils, and platelets, all of which are directly involved in immune system activities and drive the occurrence of immune responses. Its core identity on these cells is a potent immunosuppressive checkpoint, equivalent to installing a regulatable molecular brake on each immune cell, which can limit excessive activation of immune cells and prevent the body from suffering accidental damage. If the expression and regulation of LAIR1 go wrong, the body will in turn develop a series of pathological conditions, with failures falling into two main categories. One is that in the tumor microenvironment, immune cells in this environment continuously and excessively upregulate the expression of LAIR1. The overabundance and over-sensitivity of these brakes will promote local immunosuppression in the tumor, allowing cancer cells to easily evade the surveillance of the immune system and proliferate wildly in the body. The other category is that malfunctions in LAIR1's own regulatory mechanism can also induce various autoimmune diseases and chronic inflammations. In the final analysis, this abnormal function is a problem with the immune system's brakes—either they are too sensitive, and normal immune work is halted as soon as it starts, preventing the immune system from performing its role; or they fail completely, the brakes cannot be applied at all, leading to uncontrolled immune responses that turn to attack the body's own normal tissues.

Fig.1 Summary of LAIR1 expression and functions in different cells. (OA Literature)Fig.1 Summary of LAIR1 expression and functions in normal leucocytes, plasmacytoid dendritic (pDCs) cells, and tumor cells.1

LAIR1 Is A Versatile Immune Inhibitory Orchestrator

LAIR1 regulates multiple immune programs, far beyond what a simple collagen receptor can summarize:

  • Leukocyte Activation Brake: After binding to collagen, LAIR1 recruits SHP-1 and SHP-2 to the cell membrane, raising the signal threshold required for immune cells to fully activate. This means immune cells must accumulate sufficiently strong activation signals to break through the restrictions set by LAIR1 and truly initiate effector functions. This negative feedback mechanism ensures that the intensity of the immune effect matches the degree of triggering stimulation, preventing a severe immune reaction from being triggered by a minor stimulus and avoiding unnecessary damage to inflamed organs.
  • Tumor Microenvironment Modulator: In tumor tissues, the expression level of LAIR1 on the surface of infiltrating lymphoid and myeloid cells usually increases. After these LAIR1 molecules bind to collagens in the tumor-associated extracellular matrix, they create an immunosuppressive environment that weakens the cytotoxicity and cytokine production capacity of immune cells, leaving immune cells that could otherwise kill cancer cells trapped in this environment and unable to function normally.
  • Precompound Research Target: The immunosuppressive effect of LAIR1 can be regulated through engineered proteins, blocking reagents, and pathway research tools. Whether by blocking its ligand binding site or interfering with its process of recruiting phosphatases, its inhibition intensity can be adjusted.

LAIR1 Membrane Protein Product List

We have elaborately developed a full set of high-quality full-length LAIR1 membrane proteins, designed to preserve research-relevant structural features of the native receptor. This set of proteins is specifically designed to solve the inherent, unavoidable challenges in the biochemical research of inhibitory receptors of the immunoglobulin superfamily. When conducting biochemical research on such receptors, many common laboratory-prepared proteins are either incompletely truncated, or fail to maintain their natural spatial morphology, making them completely unsuitable for reliable functional experiments. Our set of proteins was developed precisely to address these widespread, bottlenecking problems. Our production process supports LAIR1-focused biochemical and functional research, with format selection guided by the intended application. Each batch undergoes research-grade quality assessment and appropriate characterization before release.

LAIR1 Protein Product

Not finding the membrane protein product you need? Contact us to start your one-stop custom service!

LAIR1 Stable Cell Line Product List

To carry out immunoregulation research, or evaluate candidate drug compounds, the first priority is to build a cell system that conforms to physiological states and can accurately reproduce the endogenous LAIR1 inhibitory signal—this is the foundation of all research. If the LAIR1 in the cells cannot transmit signals normally as it does in native cells, the results obtained, whether for mechanism testing or drug screening, will be untenable. We have used cutting-edge technology to construct stable LAIR1 stable cell lines. In these cells, LAIR1 can consistently maintain its natural cell membrane localization, without mislocalizing to the cytoplasm or other locations, and it can also generate a normal functional response when exposed to collagen, which is completely consistent with the reaction in native cells. Our cell lines include not only basic wild-type expression strains, but also relevant mutant strains, naturally occurring variant strains, and research systems integrated with reporter genes, which can cover the vast majority of your research scenarios. Every cell line undergoes rigorous identification: first, we verify that the gene integration is correct, confirming that the LAIR1 sequence is stably inserted into the cell's genome and will not be lost randomly; then we detect the surface expression level to confirm that the amount of LAIR1 on the membrane meets experimental requirements; finally, we verify normal function through multiple different activity experiments, so the cell lines are ready to use immediately upon receipt. These cell models, which allow flexible adjustment of culture scale, can be used for small-scale testing or large-scale compound screening, and are core tools for conducting mechanism of action research, screening lead regulatory compounds, and optimizing research reagents targeting the LAIR1 axis.

LAIR1 Stable Cell Line Product

Not finding the stable cell line product you need? Contact us to start your one-stop custom service!

LAIR1 Recombinant Antibody Product List

If you are advancing LAIR1-related research, you may wish to try another set of our rigorously developed monoclonal antibodies—they have defined sequences and high affinity, and are custom-designed specifically for the unique structural and functional complexity of this inhibitory immune receptor. Unlike many universal antibodies that either bind weakly or cannot adapt to various types of experiments, all these antibodies have completed pre-testing and verification, and can be used for: quantitative Western blotting experiments under reducing and non-reducing conditions, direct and sandwich ELISA experiments, flow cytometry analysis of perforated immune cell populations, as well as high-resolution immunofluorescence and confocal microscopy experiments, covering almost all the common detection experiments you use. Such wide experimental compatibility helps researchers characterize LAIR1 expression in various biological scenarios; reliable detection results can be obtained for both cell samples and tissue samples, and they can also adapt to various basic immunology research needs, allowing you to select research antibodies that fully meet your experimental requirements.

LAIR1 Recombinant Antibody Product

Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!

Product Features

  • High Purity & Activity: High purity and verified integrity for dependable downstream work.
  • Diverse Expression Systems: Choice of expression formats to match routine or specialized projects.
  • Species Reactivity: Products available for human, mouse, pig, and other species.
  • Validated Applications: Application-tested to deliver consistent signals across common lab workflows.
  • Exceptional Lot-to-Lot Consistency: Tight lot-to-lot control for reproducible performance.
  • Customization Options: Flexible customization of tags, labels, or packaging upon request.

Custom LAIR1 Membrane Protein and Antibody Discovery Services

Beyond our catalog offerings, we provide comprehensive, end-to-end protein design and engineering services tailored specifically for challenging membrane-associated enzymes like LAIR1:

  • Custom LAIR1 Protein Production: Tailored expression, purification, and characterization of challenging multi-domain receptor constructs.
  • Custom Antibody Development: From antigen design to antibody engineering (monoclonal, polyclonal, recombinant) for specific research applications.
  • Stable Cell Line Development: Generation of bespoke stable cell lines expressing your target of interest.
  • Functional Assay Development: Designing and executing assays to assess receptor activation and ligand.

Frequently Asked Questions (FAQ)

  1. Are LAIR1 reagents cleared for use in studies that involve direct administration to biological subjects?

    No. Every material directed against LAIR1—encompassing recombinant protein preparations, stable expression systems, and affinity reagents—is designated exclusively for preclinical investigation.

  2. Can you create LAIR1 variants linked to altered inhibitory signaling or autoimmune phenotypes?

    Absolutely. We have generated different mutants. These are provided as either recombinant membrane proteins or as stable cell lines.

  3. Are the anti-LAIR1 reagents effective for detecting the receptor in complex with its associated intracellular regulatory factors?

    Yes. The antibody panel has been functionally validated for specific recognition of the target when it resides alongside its membrane-proximal partners within stabilized cellular fractions. These binders show negligible cross-reactivity with unrelated immunomodulatory receptors, permitting confident delineation of specific association networks.

  4. What breadth of LAIR1-directed materials is routinely accessible?

    The standard offering spans three integrated categories: recombinant LAIR1 proteins in multiple biochemical presentations, stable expression cell lines with confirmed surface localization and activity, and epitope-mapped antibodies covering distinct structural regions of the polypeptide.

Reference
  1. Van Laethem, Francois, et al. "LAIR1, an ITIM-containing receptor involved in immune disorders and in hematological neoplasms." International Journal of Molecular Sciences 23.24 (2022): 16136. Under Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/ijms232416136
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us
© 2026 Creative Biolabs. | Contact Us
Thanksgiving Sale - up to 20% off membrane proteins and stable cell lines
Membrane Proteins Stable Cell Lines
;